Iradimed CEO Sells 7,500 Shares Indirectly
Iradimed's CEO, Roger E. Susi, sold 7,500 shares of the company's stock indirectly through trust entities on April 20 and 21, 2026. The transaction, valued at $694,125, is consistent with his recent selling pattern and had minimal impact on his overall holdings. The company's stock has risen 68.79% over the past year.
Tickers: $IRMD
Topics: executive stock sales insider trading Iradimed Corporation SEC filings